NCT00003331
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Kaplan Cancer Center New York, United States
Clinical trial condition
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Explore clinical trials studying Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.
294 public trials
62 recruiting studies
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trial results
NCT00003294
- Conditions
- Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +51 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT00646139
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +53 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT00003269
- Conditions
- Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +77 more
- Locations
-
- Scripps Clinic La Jolla, California, United States
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +136 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00010283
- Conditions
- Adnexal Diseases, Amyloidosis, Blast Crisis, +137 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00005804
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00003082
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Arizona Cancer Center Tucson, Arizona, United States
NCT00005580
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
- Locations
-
- New York Presbyterian Hospital - Cornell Campus New York, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Massey Cancer Center Richmond, Virginia, United States
Active, Not Recruiting
Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)
NCT04703192
- Conditions
- Adult T Cell Leukemia/Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- City Of Hope National Medical Center Duarte, California, United States
- Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY Palo Alto, California, United States
- University of California San Francisco San Francisco, California, United States
- University Of Colorado Cancer Center Aurora, Colorado, United States